David B. Clifford

Washington University in St. Louis — United States

Immunology and Microbiology · Life Sciences

78h-index28.1kcitations349works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(165), HIV/AIDS Research and Interventions(84), HIV-related health complications and treatments(84), Polyomavirus and related diseases(70), HIV/AIDS drug development and treatment(35)

Publications344 total

Towards pharmacological prevention of Alzheimer disease
Nature Reviews Neurology·2025· 2 cited
A Multi‐Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future Directions
Annals of Clinical and Translational Neurology·2025Open Access
<scp>ENLITE PD:</scp> A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease
Movement Disorders·2025
GATA2 mutation is associated with immune dysfunction and increased Mycobacterium haemophilum susceptibility in immunocompromised individuals
JCI Insight·2025Open Access
Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease – Authors' reply
The Lancet Neurology·2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN‐TU‐001 trial
Alzheimer s & Dementia·2025· 2 citedOpen Access
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial
Neurology Open Access·2025· 4 citedOpen Access
Consensus Recommendations for the Management of Neurosarcoidosis
Neurology Clinical Practice·2025· 14 cited
Safety of higher doses of gantenerumab in the open‐label extension of the DIAN–TU‐001 trial
Alzheimer s & Dementia·2024Open Access
Modeling the influence of presenilin‐1 mutation position on primary outcomes of a gantenerumab trial: findings from the DIAN‐TU‐001 study
Alzheimer s & Dementia·2024Open Access
Delaying symptom onset in Dominantly Inherited Alzheimer’s Disease: Long‐term gantenerumab treatment results from the DIAN‐TU trial
Alzheimer s & Dementia·2024Open Access
Insights into high‐risk or unusual ARIA: manifestations and individualized approaches to management through cases from DIAN‐TU gantenerumab open‐label study
Alzheimer s & Dementia·2024Open Access
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial
2024· 4 citedOpen Access
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
JAMA Neurology·2024· 24 citedOpen Access
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
The Journal of Prevention of Alzheimer s Disease·2024· 3 citedOpen Access
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
Alzheimer s & Dementia·2024· 13 citedOpen Access
Elevated Plasma Protein Carbonyl Concentration Is Associated with More Abnormal White Matter in People with HIV
Viruses·2023· 5 citedOpen Access
<i>Mycobacterium</i><scp><i>haemophilum</i></scp> Related Myelitis in Geographically Linked Cases
Annals of Neurology·2023· 2 cited
41 Examining the independent and additive effects of family history of dementia and apolipoprotein e4 on neurocognitive performance among people with HIV
Journal of the International Neuropsychological Society·2023Open Access
3 The Relationship Between Apolipoprotein-E4 Genotype, Memory, and the Medial Temporal Lobe and How These Relationships Vary by Race in Middle-Aged Persons with HIV
Journal of the International Neuropsychological Society·2023Open Access
page 1 of 18Next →

Frequent Co-authors

David M. Simpson(16), Justin C. McArthur(14), Ronald J. Ellis(13), Christina M. Marra(12), Igor Grant(10), Robert K. Heaton(10), Scott Letendre(10), Ann C. Collier(10), Benjamin B. Gelman(9), Susan Morgello(9), J. Allen McCutchan(9), Donald Franklin(8), Thomas D. Marcotte(6), Ian Abramson(6), Anthony Gamst(6), Christine Fennema‐Notestine(6), Eugene O. Major(6), David W. Haas(6), Steven Paul Woods(5), Florin Vaida(5)